¼ò
¤™
- ¼ò
- ·±
- EN
-
¹ØÓÚvic3308 ¤™
-
¿Æ¼¼Á¢Òì ¤™
-
²úÆ·ÓëÓªÒµ ¤™
-
ÐÂÎÅÖÐÐÄ ¤™
-
Ͷ×ÊÕß¹Øϵ ¤™
-
ESG ¤™
-
Ö°ÒµÉú³¤ ¤™
¼ò
¤™
¿ËÈÕ£¬ £¬£¬ £¬£¬¹ú¼Ê×ÅÃûÒ©ÀíѧÆÚ¿¯¡¶Frontiers in Pharmacology¡·£¨ÒëÃû£º¡¶Ò©ÀíѧǰÑØ¡·£©ÔÚÏß½ÒÏþÁË°¢ÃÀÌæÄáÕæʵÌìÏÂÖÎÁÆEGFRÍ»±äÍíÆÚ·ÇСϸ°û·Î°©µÄÁÙ´²ÁÆЧºÍÇå¾²ÐÔÆÊÎö»ØÊ×ÐÔÑо¿Ð§¹û¡£ ¡£¡£¡£¡£¡£¡£¸ÃÑо¿²»µ«±¨µÀÁËÕæʵÌìÏ°¢ÃÀÌæÄá¸ü³¤µÄÎÞÏ£ÍûÉúÑÄʱ¼ä£¨PFS£©ºÍ×ÜÉúÑÄÆÚ£¨OS£©Êý¾Ý£¬ £¬£¬ £¬£¬»¹±¨µÀÁËÓÐÖ¢×´ÄÔתÒÆ¡¢T790MÒõÐÔ¡¢¹²Í»±ä¡¢¶àÆ÷¹ÙתÒƵȻ¼ÕßµÄÁÙ´²»ñÒæ¡£ ¡£¡£¡£¡£¡£¡£
ÕâÊÇÒ»Ïî°üÀ¨173Àý»¼Õߵĵ¥ÖÐÐÄÕæʵÌìÏÂÊÓ²ìÐÔÑо¿£¬ £¬£¬ £¬£¬ÓɺÓÄÏÊ¡Ö×ÁöÒ½ÔºÍõ»Û¾ê½ÌÊÚÍŶÓÖ÷µ¼£¬ £¬£¬ £¬£¬Ö¼ÔÚÑо¿°¢ÃÀÌæÄáÕæʵÌìÏÂÖÎÁÆEGFRÍ»±äÍíÆÚ·ÇСϸ°û·Î°©µÄÁÙ´²ÁÆЧºÍÇå¾²ÐÔ¡£ ¡£¡£¡£¡£¡£¡£
Ñо¿Åú×¢£¬ £¬£¬ £¬£¬Ò»Ïß½ÓÊÜ°¢ÃÀÌæÄáÖÎÁƵÄ77Àý»¼ÕßÖУ¬ £¬£¬ £¬£¬¿Í¹Û»º½âÂÊ£¨ORR£©Îª 77.92%£¨95% CI:67.02%-86.58%£©£¬ £¬£¬ £¬£¬¼²²¡¿ØÖÆÂÊ£¨DCR£©Îª100% £¨95% CI£º95.32%-100.00%£©£¬ £¬£¬ £¬£¬ÖÐλÎÞÏ£ÍûÉúÑÄÆÚ£¨mPFS£©Îª24.97¸öÔ£¨95% CI£º19.4- NR£©£¬ £¬£¬ £¬£¬ÖÐλÉúÑÄʱ¼ä£¨mOS£©Î´µÖ´ï£¨95% CI£ºNR-NR£©¡£ ¡£¡£¡£¡£¡£¡£ºóÏß½ÓÊÜ°¢ÃÀÌæÄáÖÎÁƵÄ96Àý»¼ÕßÖУ¬ £¬£¬ £¬£¬ORRΪ46.88% £¨95% CI£º36.61%-57.33%£©£¬ £¬£¬ £¬£¬DCRΪ89.58% £¨95% CI£º81.67%-94.89%£©£¬ £¬£¬ £¬£¬mPFSΪ15.17¸öÔ£¨95% CI£º11.23¨C22.88£©£¬ £¬£¬ £¬£¬mOSΪ21.40¸öÔ£¨95% CI£º17.23-NR£©¡£ ¡£¡£¡£¡£¡£¡£
ͬʱ£¬ £¬£¬ £¬£¬Ñо¿Ð§¹û»¹Õ¹ÏÖÁË°¢ÃÀÌæÄáÓÅÒìµÄÇå¾²ÐÔ£¬ £¬£¬ £¬£¬´ó²¿·Ö²»Á¼·´Ó¦Îª1-2 ¼¶£¬ £¬£¬ £¬£¬ÔÚ¶ÔÖ¢ÖÎÁÆºó£¬ £¬£¬ £¬£¬»¼ÕßµÄÉú»¯Ö¸±ê¼°ÁÙ´²Ö¢×´¾ù»ñµÃ»º½â¡£ ¡£¡£¡£¡£¡£¡£
×÷ΪÖйúÊ׸öÔÑÐÈý´úEGFR-TKI£¬ £¬£¬ £¬£¬°¢ÃÀÌæÄáÁ¢ÒìÐÔµØÒýÈë»·±û»ù½á¹¹£¬ £¬£¬ £¬£¬¾ßÓÐÓÅÒìµÄÖ¬ÈÜÐÔºÍÎȹÌÐÔ£¬ £¬£¬ £¬£¬ÄܸüºÃµØ͸¹ýѪÄÔÆÁÕÏ£¬ £¬£¬ £¬£¬ÇÒ²»Á¼·´Ó¦±¬·¢Âʵͣ¬ £¬£¬ £¬£¬ÏÖÔÚÒѾ³ÉΪ EGFRÍâÏÔ×Ó19ȱʧ»òÍâÏÔ×Ó21 L858RÍ»±äºÍEGFR T790MÍ»±äÑôÐԵľֲ¿ÍíÆÚ»òתÒÆÐÔ NSCLC³ÉÈË»¼ÕßÍƼöÖÎÁƼƻ®¡£ ¡£¡£¡£¡£¡£¡£
º²ÉÖÆÒ©ÊÇÖйúÁìÏȵÄÁ¢ÒìÇý¶¯ÐÍÖÆÒ©ÆóÒµ£¬ £¬£¬ £¬£¬ÏÂÊôºÀÉÒ©Òµ¡¢³£Öݺã°îÒ©Òµ¡¢º²ÉÉúÎïÒ½Ò©µÈ×Ó¹«Ë¾£¬ £¬£¬ £¬£¬Öصã¹Ø×¢¿¹Ö×Áö¡¢¿¹Ñ¬È¾¡¢ÖÐÊàÉñ¾ÏµÍ³¡¢´úл¼°×ÔÉíÃâÒßµÈÖØ´ó¼²²¡ÖÎÁÆÁìÓò£¬ £¬£¬ £¬£¬ÖÂÁ¦ÓÚͨ¹ýÒ»Á¬Á¢ÒìÌá¸ßÈËÀàÉúÃüÖÊÁ¿¡£ ¡£¡£¡£¡£¡£¡£×èÖ¹ÏÖÔÚ£¬ £¬£¬ £¬£¬¹«Ë¾ÒÑÉÏÊÐ7¿îÁ¢ÒìÒ©£¬ £¬£¬ £¬£¬Á¢ÒìÒ©ÓªÊÕÕ¼±ÈÒÑÍ»ÆÆÖÁ61.8%¡£ ¡£¡£¡£¡£¡£¡£¹«Ë¾Ò»Á¬¶àÄêλ¾ÓÈ«ÇòÖÆÒ©ÆóÒµ°ÙÇ¿¡¢ÖйúÒ½Ò©Ñз¢²úÆ·Ïß×î¼Ñ¹¤ÒµÆóҵǰ3Ç¿£¬ £¬£¬ £¬£¬Êǹú¼ÒÖصã¸ßÐÂÊÖÒÕÆóÒµ¡¢¹ú¼ÒÊÖÒÕÁ¢ÒìÊ÷Ä£ÆóÒµ¡£ ¡£¡£¡£¡£¡£¡£¹«Ë¾ÓÚ2019Äê6ÔÂÔÚÏã¸ÛÁª½»Ëù¹ÒÅÆÉÏÊУ¨¹ÉƱ´úÂ룺03692.HK£©¡£ ¡£¡£¡£¡£¡£¡£¸ü¶àÐÅÏ¢Çë»á¼û£º/¡£ ¡£¡£¡£¡£¡£¡£
±¾ÎÄÖ¼ÔÚÌṩÓйء°º²ÉÖÆÒ©¼¯ÍÅÓÐÏÞ¹«Ë¾¡±»òÆä×Ó¹«Ë¾µÈ¹ØÁª·½£¨Í³³Æ¡°¹«Ë¾¡±£©µÄÏà¹ØÐÅÏ¢£¬ £¬£¬ £¬£¬²»×é³É¹«Ë¾ÐÅÏ¢Åû¶»òͶ×ÊÍƼö¡£ ¡£¡£¡£¡£¡£¡£
±¾ÎÄËùÐû²¼µÄÐÅÏ¢ÖпÉÄÜ»á°üÀ¨Ä³Ð©Ç°Õ°ÐÔ±íÊö£¬ £¬£¬ £¬£¬ÀýÈçÉæ¼°ÓªÒµºÍ²úÆ·Ô¶¾°£¬ £¬£¬ £¬£¬»ò¹«Ë¾ÍýÏë¡¢ÈÏÖª¡¢Ô¤ÆÚ¼°Õ½ÂÔ¡£ ¡£¡£¡£¡£¡£¡£ÕâЩ±íÊöÊǽ¨ÉèÔÚÍƲâÐÔ¼ÙÉèµÄÊý¾Ý»ù´¡ÉϵÄÕ¹Íû£¬ £¬£¬ £¬£¬²¢·ÇÊǶÔδÀ´Éú³¤µÄ°ü¹Ü£¬ £¬£¬ £¬£¬ÒòÆäÐÔ×ÓʹȻ¾ùÊÜÏà¹ØΣº¦ºÍ²»È·¶¨ÒòËØÓ°Ï죬 £¬£¬ £¬£¬ÆäÖв¿·Ö»¹²»Êܹ«Ë¾¿ØÖÆÇÒÄÑÒÔÔ¤ÁÏ£¬ £¬£¬ £¬£¬Í¶×ÊÕß¾ÙÐÐͶ×ʾöÒéʱӦÉóÉ÷ʹÓᣠ¡£¡£¡£¡£¡£¡£ÔÚʹÓá°ÖÂÁ¦ÓÚ¡±¡°Ô¤ÆÚ¡±¡°ÐÅÍС±¡°Õ¹Íû¡±¡°ÆÚÍû¡±¼°ÆäËûÀàËÆ´ÊÓï¾ÙÐбíÊöʱ£¬ £¬£¬ £¬£¬·²Ó빫˾ÓйصÄÐÅÏ¢±íÊö£¬ £¬£¬ £¬£¬¾ùÊôÓÚÇ°Õ°ÐÔ±íÊö¡£ ¡£¡£¡£¡£¡£¡£¹«Ë¾²¢ÎÞÒåÎñ¸üлòÐÞ¸ÄÕâЩǰհÐÔ±íÊö£¬ £¬£¬ £¬£¬¹«Ë¾¡¢¹«Ë¾¶Ê¡¢¹ÍÔ±¡¢ÊðÀí¸Å²»¼ç¸ºÒòÈκÎÇ°Õ°ÐÔ±íÊö²»¿ÉʵÏÖ»òÄð³É²»×¼È·¶øÒýÖµÄÈκÎÔðÈΡ£ ¡£¡£¡£¡£¡£¡£
±¾ÐÂΟåÖеÄËùÓÐÐÅÏ¢½ö¼°ÓÚÐÂΟåÐû²¼Ö®ÈÕ£¬ £¬£¬ £¬£¬ÎÞÂÛÊÇ·ñ·ºÆðÐÂ×ÊÁÏ¡¢Î´À´ÊÂÎñ»òÆäËûÇéÐΣ¬ £¬£¬ £¬£¬³ý·ÇÖ´·¨ÒªÇó£¬ £¬£¬ £¬£¬¹«Ë¾²¢ÎÞÔðÈλòÒåÎñ¸üлòÐ޸ĸõÈÐÅÏ¢¡£ ¡£¡£¡£¡£¡£¡£Í¶×ÊÕßÒ˲ÎÕÕº²ÉÖÆÒ©£¨03692.HK£©Í¨¸æ¼°²Æ±¨£¬ £¬£¬ £¬£¬ÒÔ»ñÈ¡½öÓëÉÏÊй«Ë¾ÓйصÄÐÅÏ¢¡£ ¡£¡£¡£¡£¡£¡£
